Millions of Kids Left Waiting as Federal Covid Vaccine Access Grinds to a Halt

A Safety Net With a Broken Lock

The federal government approved updated Covid-19 vaccines for the 2026-27 respiratory virus season last month, but the US Centers for Disease Control and Prevention has not yet made these vaccines available through a key federal program that covers access for about half of US children. As fall respiratory virus season approaches, that gap is not a minor bureaucratic hiccup — it's a real-world barrier standing between millions of kids and protection against Covid-19.

The Vaccines for Children program provides routine immunizations at no cost to children who are uninsured or underinsured or whose families may not otherwise be able to afford them. About half of US children are eligible for this program, which the CDC calls "one of the nation's most important contributors to vaccine access." In other words, this isn't a niche program on the margins — it's a cornerstone of how tens of millions of American families get vaccines for their kids.

Three Weeks and Counting

It's been three weeks since the US Food and Drug Administration approved the updated Covid-19 vaccines, and the CDC has not started the process for states and other jurisdictions to order them through Vaccines for Children. The delay was first reported by the Wall Street Journal. That lag is significant. Flu season doesn't wait for paperwork, and Covid-19 has historically surged alongside other respiratory viruses in the fall and winter months.

The CDC's Advisory Committee on Immunization Practices (ACIP) must formally vote to recommend a vaccine before it can be covered and distributed through the Vaccines for Children program, but the panel has been in disarray since March, when a federal judge temporarily blocked an HHS overhaul of the vaccine schedule and ruled that Secretary Robert F. Kennedy Jr.'s decision to replace committee members last year did not follow federal legal procedures. ACIP hasn't met since. Without that committee functioning, the formal recommendation process — a required step — simply cannot happen.

Political Turmoil at the Heart of the Problem

The dysfunction surrounding ACIP is the direct result of an ongoing legal and political battle over who controls vaccine policy in the United States. Critics have been pointed in their assessment of what this means on the ground. "The Administration promised that changes to the federal vaccine process would not interfere with families' ability to access recommended vaccines, yet that is exactly what is occurring," said one critic of the administration's approach.

Speaking at the conference of the anti-vaccine organization Children's Health Defense, Kennedy acknowledged that litigation is continuing but repeated an argument he often makes: "We have not taken vaccines away from anyone." That framing, however, is increasingly difficult to square with the reality facing families whose children cannot access a federally approved vaccine through the program designed specifically to reach them.

What This Means for Families Right Now

For parents with private insurance, the updated Covid-19 vaccines may still be accessible through a pediatrician's office or pharmacy. But for the roughly half of American children who rely on the Vaccines for Children program, the path forward is unclear. The vaccines exist, they've been approved, and yet the bureaucratic and legal machinery needed to get them to the most vulnerable kids remains jammed.

An appeal is seeking "to restore a functioning ACIP so the vaccine recommendation process can continue, and families, physicians, and public health programs have the guidance they need." Until that happens — or until the administration finds another legal pathway — millions of children will head into fall without the same access to Covid protection that a functioning federal system was always supposed to guarantee. The longer this drags on, the more the cost is measured not in legal fees, but in missed vaccines.